Konstantinos Stefanakis

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Extracorporeal Membrane Oxygenation

Skeletal Muscle

Top Venues

Nature communications

Diabetes, obesity & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Sofia K Konstantinidou, Georgia Argyrakopoulou, Stamatia Simati, Konstantinos Stefanakis, Alexander Kokkinos, Antonis Analitis, Christos S Mantzoros
Total and H-specific growth/differentiation factor 15 levels are unaffected by liraglutide or naltrexone/bupropion administration. Diabetes, obesity & metabolism (2024)
Pavlina Chrysafi, Laura Valenzuela-Vallejo, Konstantinos Stefanakis, Theodoros Kelesidis, Margery A Connelly, Christos S Mantzoros
Total and H-specific GDF-15 levels increase in caloric deprivation independently of leptin in humans. Nature communications 15 (1) (2024)
Pavlina Chrysafi, Laura Valenzuela-Vallejo, Konstantinos Stefanakis, Theodoros Kelesidis, Margery A Connelly, Christos S Mantzoros
Total and H-specific GDF-15 levels increase in caloric deprivation independently of leptin in humans. Nature communications 15 (1) (2024)
Pavlina Chrysafi, Laura Valenzuela-Vallejo, Konstantinos Stefanakis, Theodoros Kelesidis, Margery A Connelly, Christos S Mantzoros
Total and H-specific GDF-15 levels increase in caloric deprivation independently of leptin in humans. Nature communications 15 (1) (2024)
Pavlina Chrysafi, Laura Valenzuela-Vallejo, Konstantinos Stefanakis, Theodoros Kelesidis, Margery A Connelly, Christos S Mantzoros
Total and H-specific GDF-15 levels increase in caloric deprivation independently of leptin in humans. Nature communications 15 (1) (2024)
Sofia K Konstantinidou, Georgia Argyrakopoulou, Stamatia Simati, Konstantinos Stefanakis, Alexander Kokkinos, Antonis Analitis, Christos S Mantzoros
Total and H-specific growth/differentiation factor 15 levels are unaffected by liraglutide or naltrexone/bupropion administration. Diabetes, obesity & metabolism 26 (8) (2024)
Konstantinos Stefanakis, Alexander Kokkinos, Georgia Argyrakopoulou, Sofia K Konstantinidou, Stamatia Simati, Matina Kouvari, Ajay Kumar, Bhanu Kalra, Melina Kumar, Nikolaos Bontozoglou, Konstantina Kyriakopoulou, Christos S Mantzoros
Circulating levels of proglucagon-derived peptides are differentially regulated by the glucagon-like peptide-1 agonist liraglutide and the centrally acting naltrexone/bupropion and can predict future weight loss and metabolic improvements: A 6-month long interventional study. Diabetes, obesity & metabolism (2023)